Valuation dashboard for Sintx Technologies, Inc. (SINT) with P/E N/A, P/B 1.69, EV/EBITDA -0.92 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States.
Analysis Summary
Sintx Technologies, Inc. reported revenue of $1.0M in the most recent fiscal year, growing at a 5-year CAGR of 11.4%.
Trailing-twelve-month margins: gross margin -4.6%, operating margin -8.5%, net margin -13.0%.
At the current price of $1.68, SINT has negative trailing earnings (P/E not meaningful) and an ROE of -5.66%. Market capitalisation stands at $11M.
Balance sheet quality for SINT: current ratio of 1.5. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.69 |
| EV / EBITDA | -0.92 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-7.30 |
| vs Current Price | -534.8% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| SINT | Sintx Technologies, Inc. | $11M | 1.69 | -5.7% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 28.37 | 4.41 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $65.3B | 17.84 | 2.62 | 14.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $1.68 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -565.55% |
| Return on Invested Capital | -149.36% |
| Return on Assets | -172.58% |
| Gross Margin | -4.63% |
| Operating Margin | -852.14% |
| Net Margin | -1303.40% |
Related companies: DHAI · HSCS · IINN · LFWD · PFSA · PTHL · RNAZ
Explore sector: Healthcare · Medical - Devices
More sections of SINT: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks